NCT02965170View on ClinicalTrials.gov

Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS

CompletedOBSERVATIONAL

Enrollment

109

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

May 31, 2018

Conditions

Multiple Sclerosis

Trial Locations (1)

84103

Rocky Mountain MS Clinic, Salt Lake City

Sponsors

Collaborators (1)

Abreos Biosciences

All Listed Sponsors

collaborator

Abreos Biosciences

OTHER

lead

Rocky Mountain MS Research Group, LLC

OTHER

NCT02965170 - Validation of a Laboratory Test Measuring Natalizumab (Tysabri®) Serum Levels in MS | Biotech Hunter | Biotech Hunter